TrialBritish journal of clinical pharmacology2007

A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans.

Joseph A Jakubowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.